Skip to content
Publish & Distribute
Publishing Solutions
Distribution Solutions
Library Services
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Journal Matcher
Blog
Contact
Search
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Radiology and Oncology
Volume 49 (2015): Issue 1 (March 2015)
Open Access
Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience
Tanja Mesti
Tanja Mesti
Search for this author on
Sciendo
|
Google Scholar
Mesti, Tanja
,
Maja Ebert Moltara
Maja Ebert Moltara
Search for this author on
Sciendo
|
Google Scholar
Ebert Moltara, Maja
,
Marko Boc
Marko Boc
Search for this author on
Sciendo
|
Google Scholar
Boc, Marko
,
Martina Rebersek
Martina Rebersek
Search for this author on
Sciendo
|
Google Scholar
Rebersek, Martina
and
Janja Ocvirk
Janja Ocvirk
Search for this author on
Sciendo
|
Google Scholar
Ocvirk, Janja
Mar 03, 2015
Radiology and Oncology
Volume 49 (2015): Issue 1 (March 2015)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Download Cover
Published Online:
Mar 03, 2015
Page range:
80 - 85
Received:
Sep 09, 2013
Accepted:
Nov 08, 2013
DOI:
https://doi.org/10.2478/raon-2014-0021
Keywords
recurrent malignant glioma
,
bevacizumab
,
irinotecan
,
systemic therapy
© by Janja Ocvirk
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
